The role of rosiglitazone treatment in the modulation of islet hormones and hormone-like peptides: A combined in situ hybridization and immunohistochemical study

Journal of Molecular Histology

Volumn 39, Issue 6, 2008, Pages 635-642

  Yildirim, Sukriye ^a   Bolkent, Sema ^b   Sundler, Frank ^c  

^a INSTITUTE OF MOLECULAR GENETICS   (Czech Republic)

^b ISTANBUL UNIVERSITY   (Turkey)

^c LUND UNIVERSITY   (Sweden)

Author keywords

Diabetic rats; Immunohistochemistry; In situ hybridization; Islet hormones; Rosiglitazone

Indexed keywords

ROSIGLITAZONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; PANCREAS ISLET CELL; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; HORMONES; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; ISLETS OF LANGERHANS; MALE; PEPTIDES; PPAR GAMMA; RATS; RATS, WISTAR; THIAZOLIDINEDIONES;

ANIMALIA; RATTUS;

EID: 56349114408     PISSN: 15672379     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10735-008-9204-z     Document Type: Article

References (36)

1. B Ahren 2007 Insulin secretion and insulin sensitivity in relation to fasting glucose in healthy subjects Diabetes Care 30 644 648 10.2337/dc06-1759
2. B Ahren F Sundler 1992 Localization of calcitonin gene-related peptide and islet amyloid polypeptide in the rat and mouse pancreas Cell Tissue Res 269 315 322 10.1007/BF00319623
3. A Ali-Rachedi IM Varndell TE Adrian DA Gapp SV Noorden SR Bloom JM Polak 1984 Peptide YY (PYY) immunoreactivity is co-stored with glucagon-related immunoreactants in endocrine cells of the gut and pancreas Histochem Cell Biol 80 487 491 10.1007/BF00495439
4. G Böttcher B Ahren I Lundquist F Sundler 1989 Peptide YY: intrapancreatic localization and effects on insulin and glucagon secretion in the mouse Pancreas 4 282 288
5. G Böttcher J Sjöberg R Ekman R Hakanson F Sundler 1993 Peptide YY in the mammalian pancreas: immunocytochemical localization and immunochemical characterization Regul Pept 43 115 130 10.1016/0167-0115(93)90146-Y
6. MJ Castillo AJ Scheen PJ Lefebvre 1995 Amylin/islet amyloid polypeptide: biochemistry, physiology, patho-physiology Diabetes Metab 21 3 25
7. L Chen I Komiya L Inman K McCorkle T Alam RH Unger 1989 Molecular and cellular responses of islets during perturbations of glucose homeostasis determined by in situ hybridization histochemistry Proc Natl Acad Sci USA 86 1367 1371 10.1073/pnas.86.4.1367
8. M Dubois F Pattou J Kerr-Conte V Gmyr B Vandewalle P Desreumaux J Auwerx K Schoonjans J Lefebvre 2000 Expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) in normal human pancreatic islet cells Diabetologia 43 1165 1169 10.1007/s001250051508
9. RL Gingerich DJ Gersell MH Greider EH Finke PE Lacy 1978 Elevated levels of pancreatic polypeptide in obese-hyperglycemic mice Metabolism 27 1526 1532 10.1016/S0026-0495(78)80025-0
10. C Huin L Corriveau A Bianchi JM Keller P Collet P Kremarik-Bouillaud L Domenjoud P Becuwe H Schohn D Menard M Dauca 2000 Differential expression of peroxisome proliferator-activated receptors (PPARs) in the developing human fetal digestive tract J Histochem Cytochem 48 603 611
11. Y Iwashima K Watanabe I Makino 1990 Changes in the pancreatic A, B- and D-cell populations during development of diabetes in spontaneously diabetic Chinese hamsters of the Asahikawa colony (CHAD) Diabetes Res Clin Pract 8 201 214 10.1016/0168-8227(90)90118-D
12. PB Jensen P Kristensen JT Clausen ME Judge S Hastrup L Thim BS Wulff C Foged J Jensen JJ Holst OD Madsen 1999 The hypothalamic satiety peptide CART is expressed in anorectic and non-anorectic pancreatic islet tumors and in the normal islet of Langerhans FEBS Lett 447 139 143 10.1016/S0014-5793(99)00291-4
13. KH Johnson TD O'Brien DW Hayden K Jordan HK Ghobrial WC Mahoney P Westermark 1988 Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein A-gold techniques Am J Pathol 130 1 8
14. 2 in the modulation of insulin secretion Am J Physiol Endocrinol Metab 286 560 567 10.1152/ajpendo.00561.2002
15. Y Manaka M Watanabe K Yamaguchi H Managa T Kato K Yamatani M Tominaga H Sasaki 1998 Sequential changes in CGRP-like immunoreactivity in NIDDM model Otsuka Long-Evans Tokushima Fatty (OLETF) rat pancreatic islets Pancreas 17 72 79 10.1097/00006676-199807000-00009
16. A Masamune K Kikuta M Satoh Y Sakai A Satoh T Shimosegawa 2002 Ligands of peroxisome proliferator-activated receptor-gamma block activation of pancreatic satellite cells J Biol Chem 277 141 147 10.1074/jbc.M107582200
17. P Mukunyadzi L Ai D Portilla EL Barnes CY Fan 2003 Expression of peroxisome-activated receptor gamma in salivary duct carcinoma: immunohistochemical analysis of 15 cases Mod Pathol 16 1218 1223 10.1097/01.MP.0000096042.70559.7E
18. H Mulder A-C Lindh F Sundler 1993 Islet amyloid polypeptide gene expression in the endocrine pancreas of the rat: a combined in situ hybridization and immunocytochemical study Cell Tissue Res 274 467 474 10.1007/BF00314543
19. H Mulder B Ahren F Sundler 1995 Differential expression of islet amyloid polypeptide (amylin) and insulin in experimental diabetes in rodents Mol Cell Endocrinol 114 101 109 10.1016/0303-7207(95)03646-O
20. U Myrsén-Axcrona E Ekblad F Sundler 1997 Developmental expression of NPY, PYY and PP in the rat pancreas and their coexistence with islet hormones Regul Pept 68 165 175 10.1016/S0167-0115(96)02113-1
21. YC Patel GC Weir 1976 Increased somatostatin content of islets from streptozotocin-diabetic rats Clin Endocrinol (Oxf) 5 191 194 10.1111/j.1365-2265.1976.tb02832.x
22. SM Rangwala AL Mitchell 2004 Peroxisome proliferator-activated receptor γ in diabetes and metabolism Trends Pharmacol Sci 25 331 336 10.1016/j.tips.2004.03.012
23. T Shibata S Takeuchi S Yokota K Kakimoto F Yonemori K Wakitani 2000 Effects of peroxisome proliferator-activated receptor- α and-γ agonist, JTT-501, on diabetic complications in Zucker diabetic fatty rats Br J Pharmacol 130 495 504 10.1038/sj.bjp.0703328
24. DM Smith SR Bloom 1995 Paracrine/autocrine control of the islet and amylin family Biochem Soc Trans 23 336 340
25. Sundler F, Böttcher G, Ekblad E, Hakanson R (1993) PP, PYY, and NPY: occurrence and distribution in the periphery. In: Colmers WF, Wahlestedt C (eds) The biology of neuropeptide Y and related peptides. Humana Press Inc., Totowa, pp 157-196
26. N Suwaki H Masuyama A Masumoto N Takamoto Y Hiramatsu 2007 Expression and potential role of peroxisome proliferator-activated receptor gamma in the placenta of diabetic pregnancy Placenta 28 315 323 10.1016/j.placenta.2006.04. 002
27. GJ Taborsky Jr B Ahren PJ Havel 1998 Autonomic mediation of glucagon secretion during hypoglycemia Diabetes 47 995 1005 10.2337/diabetes.47.7.995
28. T Takamura H Ando Y Nagai H Yamashita E Nohara K Kobayashi 1999 Pioglitazone prevents mice from multiple low-dose streptozotocin-induced insulitis and diabetes Diabetes Res Clin Pract 44 107 114 10.1016/S0168-8227(99) 00030-3
29. RH Unger 1978 Role of glucagon in the pathogenesis of diabetes: the status of the controversy Metabolism 27 1691 1709 10.1016/0026-0495(78)90291-3
30. X Wang WY Yang JZ Xiao 2005 The effect of high fat feeding and rosiglitazone intervention on pancreatic alpha cell in rats Zhonghua Nei Ke Za Zhi 44 601 605
31. P Westermark E Wilander GT Westermark KH Johnson 1987 Islet amyloid polypeptide-like immunoreactivity in the islet B cells of type 2 (non-insulin dependent) diabetic and non-diabetic individuals Diabetologia 30 887 892
32. N Wierup H Svensson H Mulder F Sundler 2002 The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas Regul Pept 107 63 69 10.1016/S0167-0115(02)00067-8
33. N Wierup M Kuhar BO Nilsson H Mulder E Ekblad F Sundler 2004 Cocaine- and amphetamine-regulated transcript is expressed in several islet cell types during rat development J Histochem Cytochem 52 169 177
34. N Wierup M Bjorkqvist MJ Kuhar H Mulder F Sundler 2006 CART regulates islet hormone secretion and is expressed in the beta-cell of type 2 diabetic rats Diabetes 55 305 311 10.2337/diabetes.55.02.06.db04-1383
35. C Yang TJ Chang JC Chang MV Liu TY Tai WH Hsu LM Chuang 2001 Rosiglitazone (BRL 49653) enhances insulin secretory response via phosphatidylinositol 3-kinase pathway Diabetes 50 2598 2602 10.2337/diabetes.50. 11.2598
36. S Yildirim F Sundler S Bolkent 2007 Ghrelin and insulin gene expression changes in streptozotocin-induced diabetic rats after rosiglitazone pretreatment Eur J Histochem 51 11 18